<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bruton's XLA and <z:mp ids='MP_0002538'>DiGeorge syndrome</z:mp> patients show that two basic immune systems are distinct from each other in humans - thymus-dependent cell-mediated <z:hpo ids='HP_0002721'>immunodeficiencies</z:hpo> vs. antibody-based <z:hpo ids='HP_0002721'>immunodeficiencies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The appendix-sacculus lymphoid organ of rabbits, like the bursa of Fabricius, represents a central lymphoid organ </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0740451" disease_type="Disease or Syndrome" abbrv="">granulomatous disease</z:e> of childhood (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CGD</z:e>) revealed that phagocytosis killing of catalase-positive microorganisms employ oxidative burst </plain></SENT>
<SENT sid="3" pm="."><plain>Bone marrow transplantation (BMT) proved life saving in <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo> (<z:mp ids='MP_0002536'>SCID</z:mp>) </plain></SENT>
<SENT sid="4" pm="."><plain>The first BMT cured <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">XSCID</z:e> and the second BMT cured a complicating <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> launching BMT as a treatment of many diseases </plain></SENT>
<SENT sid="5" pm="."><plain>Now 75 fatal diseases have been cured by myeloablative BMT </plain></SENT>
<SENT sid="6" pm="."><plain>BMT also cured experimental <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>BMT alone did not cure <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> with <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> in MRL/lpr mice or <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> in NZB/KN mice, but BMT plus bone (stromal cell) transplants cured these diseases </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0002960'>Autoimmune diseases</z:hpo> and lethal <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> were prevented or cured in BXSB mice by mixed allogeneic plus syngeneic BMT </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:e sem="disease" ids="C0272236" disease_type="Disease or Syndrome" abbrv="">Hyper IgM syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">XHIM</z:e>) was also cured by BMT from a 2-year-old MHC-matched sibling donor </plain></SENT>
<SENT sid="10" pm="."><plain>Nonmyeloablative BMT plus mesenchymal stem cells (stromal cells) was effective treatment for a form of <z:e sem="disease" ids="C0262428" disease_type="Disease or Syndrome" abbrv="">collagen-vascular disease</z:e> and also a lethal form of <z:e sem="disease" ids="C0020630" disease_type="Disease or Syndrome" abbrv="">hypophosphatasia</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="1" ids="28808">Mannan</z:chebi>-binding lectin, an opsonin that activates the complement system when mutated and at low levels in blood, opens a door to <z:hpo ids='HP_0002719'>frequent infections</z:hpo> throughout childhood and adult life </plain></SENT>
<SENT sid="12" pm="."><plain>This new <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> is based on genetic mutations that involve a native defense system </plain></SENT>
</text></document>